Concepedia

He Xu

HX

Statistics

Publications

7

Citations

210

H-Index

7

Active since

2018

Affiliations

Peking University(Current)

Peking University First Hospital

Tianjin Medical University Cancer Institute and Hospital

He Xu is an author at Peking University specializing in life sciences, oncology, and molecular biology.

Publications per year

2018–2024

7

Publications

7

SPP1 Promotes Enzalutamide Resistance and Epithelial‐Mesenchymal‐Transition Activation in Castration‐Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways

Xiaocong Pang, Junling Zhang, He Xu et al. · Oxidative Medicine and Cellular Longevity · 2021 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

He Xu, Abdalla M. Wedn, Jian Wang et al. · Pharmacological Research · 2024 · 40 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Ablation of insulin receptor substrates 1 and 2 suppresses <i>Kras</i> -driven lung tumorigenesis

He Xu, Min-Sik Lee, Pei-Yun Tsai et al. · Proceedings of the National Academy of Sciences · 2018 · 24 citations · Full text

Life Sciences, Molecular Genetics, Oncology +17

Structural insights into the conformational changes of BTR1/SLC4A11 in complex with PIP2

Yishuo Lu, Peng Zuo, Hongyi Chen et al. · Nature Communications · 2023 · 23 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer

Bingqi Dong, Yanlun Gu, Xiaojiao Sun et al. · Advanced Healthcare Materials · 2024 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7